This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Molecure S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Damian Kusmirek - Innovator in Therapeutic Applications
Introduction
Damian Kusmirek is an inventor based in Czerniewice, Poland. He is currently associated with Molecure S.A., where he focuses on developing innovative therapeutic solutions. Although he does not have any granted patents, his work in the field of therapeutic applications is noteworthy.
Latest Patent Applications
Damian Kusmirek's notable patent application is titled "YKL-40 Inhibitors and Their Therapeutic Applications." This invention pertains to novel inhibitors of chitinase-like protein YKL-40 and their therapeutic applications. Such YKL-40 inhibitors are valuable as therapeutic agents for treating a variety of diseases and disorders, including cancers, inflammation, and pulmonary diseases.
Conclusion
Damian Kusmirek's contributions to the field of therapeutic applications highlight his innovative approach to addressing significant health challenges. His work continues to pave the way for potential advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile